ANAPLASTIC THYROID CANCER

Clinical trials for ANAPLASTIC THYROID CANCER explained in plain language.

Never miss a new study

Get alerted when new ANAPLASTIC THYROID CANCER trials appear

Sign up with your email to follow new studies for ANAPLASTIC THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 4 Completed 1 Terminated 1

Immunotherapy combo tested for tough thyroid cancers

Disease control Terminated

This phase II trial tested two immunotherapy drugs, durvalumab and tremelimumab, in 79 patients with advanced thyroid cancer that had progressed despite treatment. The goal was to see if the combination could slow or stop cancer growth. The study was terminated early, so the full…

Matched conditions: ANAPLASTIC THYROID CANCER

Phase: PHASE2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

ANAPLASTIC THYROID CANCER

Get alerted when new ANAPLASTIC THYROID CANCER trials appear

Immunotherapy combo tested for tough thyroid cancers